# Munich Court Overturns Injunction Against Merck in Keytruda Patent Dispute

By Riza Dagoc

Canonical URL: https://www.tokenpost.com/news/regulation/61440
Published: 2026-11-19T15:04:56.000Z
Updated: 2026-11-19T15:04:56.000Z
Section: Regulation

> The dispute involves Halozyme and Merck over Merck’s injectable version of Keytruda.

Halozyme shares fell Thursday after a Munich court overturned a preliminary injunction against Merck in a patent dispute over Merck’s injectable version of Keytruda.

The injunction was issued last year. The patent dispute involves Halozyme and Merck over Merck’s injectable version of Keytruda.


